T1	Participants 30 122	remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B
T2	Participants 199 265	patients undergoing remission induction therapy for acute leukemia
T3	Participants 753 823	Adults with acute leukemia undergoing remission induction chemotherapy
T4	Participants 1299 1310	36 patients
T5	Participants 1387 1398	41 patients
T6	Participants 1823 1894	patients undergoing remission induction chemotherapy for acute leukemia
